The high eye pressure seen in glaucoma slowly leads to blindness. For some, the first-line treatment, eye drops, doesn’t work. Researchers have used gene therapy to develop a promising new way of ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Using an experimental gene therapy, Harvard scientists have successfully restored vision to mice suffering glaucoma by effectively rewinding the aging process in their cells. While still in the early ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma is the second leading cause of blindness in the U.S. A primary screening tool for glaucoma is ...

Experts highlight early detection and the goals of therapy when managing patients with glaucoma. Neil Minkoff, MD: We’ve done the education and we have the primary care physician referring the patient ...

TUCSON, Ariz. & LONDON--(BUSINESS WIRE)--RadianceTx™, a leader in ophthalmic therapeutic innovation, today announced a $1 million first tranche closing of a targeted $7 million round of financing. The ...

Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy. Neil Minkoff, MD: Dr Stephens, could you also weigh in on how utilization ...

A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to new research. The findings suggest a way forward for developing neuroprotective ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Age of menopause was the greatest predictor of age at ...

The FINANCIAL — Glaucoma patients struggling to adhere to a daily eye drop schedule may benefit from a nonsurgical inset that researchers say ensures effective delivery of intraocular pressure ...

This study was carried out according to French law and the French Epidemiology Guidelines. [27] The study was presented to a local Institutional Review Board, and oral patient consent was obtained ...